[1] Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmmune hepatitis. Cell Mol Immunol, 2022, 19(2):158-176. [2] Hu M, You Z, Li Y, et al. Serum biomarkers for autoimmune hepatitis type 1: the case for CD48 and a review of the literature. Clin Rev Allergy Immunol, 2022, 63(3):342-356. [3] Mouchli M, Reddy S, Gerrard M,etal. Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma. Ann Hepatol, 2021, 22:100249. [4] Hung HC, Lee JC, Wang YC, et al. Living-donor liver transplantation for hepatocellular carcinoma: impact of the MELD score and predictive value of NLR on survival. Curr Oncol, 2022, 29(6):3881-3893. [5] Huang N, Chen J, Wei Y, et al. Multi-marker approach using C-reactive protein, procalcitonin, neutrophil CD64 index for the prognosis of sepsis in intensive care unit: a retrospective cohort study. BMC Infect Dis, 2022, 22(1):662. [6] Yu L, Cen P, Zhang L, et al. Neutrophil CD64 index as a good biomarker for early diagnosis of bacterial infection in pregnant women during the flu season. Influenza Other Respir Viruses, 2023, 17(8):e13191. [7] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识(2015年).中华肝脏病杂志,2016,24(1):23-35. [8] Liu Q, Gao Y, Yang T, et al. nCD64 index as a novel inflammatory indicator for the early prediction of prognosis in infectious and non-infectious inflammatory diseases: an observational study of febrile patients. Front Immunol, 2022, 13:905060. [9] Li Y, Sun Y, Liu Y, et al. Genome-wide meta-analysis identifies susceptibility loci for autoimmune hepatitis type 1. Hepatology, 2022, 76(3):564-575. [10] Jiang R, Tang J, Zhang X, et al. CCN1 promotes inflammation by inducing IL-6 production via α6β1/PI3K/Akt/NF-κB pathway in autoimmune hepatitis. Front Immunol, 2022, 13:810671. [11] Gong P, Liu Y, Gong Y, et al. The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke. J Neuroinflammation, 2021, 18(1):51. [12] 牛义善,郭藩盛,曹经琳,等.NLR联合PLR评分与肝细胞癌肝移植预后的相关性研究.中华器官移植杂志,2023,44(3):172-177. [13] Shavakhi M, Nourigheimasi S, Dioso E, et al. Prognostic role of neutrophil to lymphocyte ratio in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Can J Gastroenterol Hepatol, 2022, 2022:1554079. [14] 时克,侯杰,张艺,等.基于中性粒细胞/淋巴细胞比值探讨扶正化瘀胶囊降低乙型肝炎肝硬化患者肝细胞癌的发生率.中华肝脏病杂志,2023,31(9):969-973. [15] 张岚,李妍,杨宁,等.红细胞分布宽度和中性粒细胞/淋巴细胞比值评估原发性胆汁性胆管炎患者肝损伤临床价值研究.实用肝脏病杂志,2022,25(3):367-370. [16] Domerecka W, Kowalska-Kępczyńska A, Homa-Mlak I, et al. The usefulness of extended inflammation parameters and systemic inflammatory response markers in the diagnostics of autoimmune hepatitis. Cells, 2022, 11(16):2554. [17] 伍慧丽,时红波,段钟平.淋巴细胞在自身免疫性肝炎发病机制中的作用.中华肝脏病杂志,2022,30(3):335-339. [18] 刘倩倩,高岩,邵凌云,等.中性粒细胞CD64在感染性疾病诊断中的应用现状.中华传染病杂志,2020,38(6):381-384. [19] Pham HM, Nguyen DLM, Duong MC,etal. Diagnostic value of neutrophil CD64 in sepsis patients in the intensive care unit: a cross-sectional study. Diagnostics (Basel), 2023, 13(8):1427. [20] 朱磊,刘倩倩,徐媛媛,等.中性粒细胞CD64指数对播散性非结核分枝杆菌感染诊断价值的评估.中华传染病杂志,2023,41(5):316-319. [21] González-López E, Odriozola Herrán A, Renuncio García M, et al. CD64 expression on neutrophils as a potential biomarker for bacterial infection in ascitic fluid of cirrhotic patients. Infect Dis (Lond), 2023, 55(9):646-652. [22] Pandey G, Singh H, Chaturvedi S, et al. Utility of neutrophil CD64 in distinguishing bacterialinfection from inflammation in severe alcoholic hepatitis fulfilling SIRS criteria. Sci Rep, 2021, 11(1):19726. [23] 王菁,毕宁,方亮,等.乙型肝炎肝硬化并发自发性细菌性腹膜炎患者CD64指数及血清sTREM-1和IL-6水平变化与肠黏膜屏障功能关系研究.实用肝脏病杂志,2022,25(1):79-82. |